Email Print this page Bookmark this page

Patient Testimonials

Are you thinking about prescribing LACRISERT® to your Dry Eye patients? Hear what other LACRISERT® users have to say:

  • Janie is a bookkeeper and a Dry Eye sufferer since 1991. Click to hear about Janie’s improvement of symptoms after using LACRISERT®.

  • Susan was a book editor but she had to go on disability due to her severe Dry Eye from Sjögren’s syndrome. Click to learn more about how tolerable her Dry Eye has become since she started LACRISERT®.

  • Cynthia is a graduate student whose Dry Eye due to rheumatoid arthritis made her academic studies difficult to maintain. Click to learn more about Cynthia’s experience with LACRISERT® and how easy it is to use.

LACRISERT® is indicated in patients with moderate to severe Dry Eye syndromes, including keratoconjunctivitis sicca. LACRISERT® is indicated especially in patients who remain symptomatic after an adequate trial of therapy with artificial tear solutions. LACRISERT® is also indicated for patients with exposure keratitis, decreased corneal sensitivity, and recurrent corneal erosions.

Important Safety Information
Do not use LACRISERT® if you are allergic to hydroxypropyl cellulose. Instructions for inserting and removing LACRISERT® should be carefully followed. If improperly placed, LACRISERT® may result in a scratch to the cornea of your eye. Because LACRISERT® may cause temporary blurred vision, please use caution when driving or operating machinery. Rubbing the eye(s) containing LACRISERT® should be avoided. You should always discuss this safety information with your doctor. The following adverse reactions have been reported but were in most instances mild and temporary: temporary blurring of vision, eye discomfort or irritation, matting or stickiness of eyelashes, increased sensitivity to light, eyelid swelling, and eye redness. Talk to your doctor if you have side effects that bother you or that do not go away. You are encouraged to report side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

sample request using Lacrisert video patient tip sheet
©2009 Aton Pharma, Inc. All Rights Reserved.